Transforming DART Research
Automated, fast, and scalable 3Rs in vivo toxicity testing at the in vitro scale
Nagi Bioscience leverages the SydLab™ One platform and its in vivo model to deliver precise, high-throughput toxicity assessments.
SydLab™ One accelerates safety and toxicology studies providing high translational value while eliminating the ethical concerns of vertebrate testing.
End-to-end automation, user-independent results
Minimizing the need for vertebrate models and associated ethical concerns.
High throughput, 3Rs in vivo data at the in vitro scale
Identify mechanisms of action of your genetic interventions and candidate compounds.
Cost-effective early
results
Early in vivo testing for more accurate predictions of human outcomes.
The SydLab™ Advantage
Provides a faster, more cost effective model than vertebrate testing, while remaining as efficient as cell culture models
Speed up experiments; ensure consistency and lower costs with SydLab’s automated processes
Comprehensive in vivo / in vitro screening and higher cost effectiveness
SydLab™ One’s advanced high-content imaging of helps you analyse diverse phenotypes and supports a broad applications spectrum
Gain actionable, early insights through an established, human-relevant model
Support drug mechanism analysis with SydLab™’s technology-driven healthspan and lifespan metrics
Data in Action
Readouts
- Growth parameters
- Sexual Maturity
- Egg accumulation and survival
- Progeny apparition
- Progeny growth parameters
- NOAEL
